Position
Squarepoint Ops LLC in Inhibrx Biosciences, Inc.
Back to the book · All holders of INBX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$40K$79.00 → $67.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.4K | $268.4K | — | — | — | 0.0% |
| Q1 2026 | 15.6K | $1.05M | $67.23 | −$40K | $823K | 0.0% |